journal oncolog abstract acut myeloid leukemia common sever form acut leukemia diagnos adult owe divid class associ differ treatment outcom specif gene express profil base previou studi studi design gener amlarray contain probe human gene implic cell matura tion apoptosi leukem amlarray use hybrid sampl patient subtyp healthi volunt rigor analysi microarray data reveal gene express patient includ gene discus context express gene kitlg kra cebpa srgn wherea gene ptrpe gene specif mutat although method subgroup approa che enabl identifi gene whose express use studi subtyp express level gene increas wherea decreas compar group also examin associ gene mutat statu associ highest express upregul mutat statu moreov result indic gene express level correl respons therapi express highest patient remain longer complet remiss wherea express increas treatment resist whole studi amlarray potenti serv firstlin screen tool help diagnosi wherea subgroup perform pcrbase analysi marker gene acut myeloid leukemia common sever form acut leukemia adult respons highest mortal leukemia gener origin entir elucid diseas begin bone marrow stem cell expo complex interplay hereditari factor myeloid progenitor cell growth lead clonal expans bone marrow myeloblast peripher blood gene express profil acut myeloid leukemia sampl adult patient boutiqu microarray realtim droplet digit luiza maciej marek michał magdalena marzena barbara krzysztof mieczysław marek center genom institut bioorgan chemistri polish academi scienc poznan hematolog bone marrow poznan univers medic scienc poznan technolog chemic engin poznan univers technolog poznan comput scienc poznan univers technolog poznan poland receiv septemb accept decemb luiza handschuh european center genom institut bioorgan chemistri polish academi scienc poznan poland email acut myeloid leukemia cnaml cyto genet normal ddpcr droplet digit leukemia polymeras chain reaction word acut myeloid leukemia gene express profil microarray boutiqu array rtqpcr realtim droplet digit handschuh gene express profil acut myeloid leukemia therefor number immatur leukocyt increas normal blood cell product impair type cancer subset molecularli differ type accord first disord system type specif charac terist stage recent world health base combin clinic symptom cell morpholog immuno phenotyp genet patient clonal chromosom present result fusion gene pmlrarα larg group patient normal karyotyp nkaml cnaml normal recurr small mutat identifi usual occur gene encod signal protein factor chromatin modifi affect cell signal gener gene express frequent mutat cebpa nraskra mutat clinic relev diagnost prognost marker potenti therapeut target develop microarray next gener sequenc contribut progress leukemia research sinc first microarray leukemia classifica tion outcom predict mani base gene express profil hemato logic appear among sever hundr focus exampl shown certain genet alter correspond specif gene express signatur gene express profil also correl prognosi treatment outcom howev clinic practic white blood cell count blood karyo type still outcom diagnost test base singl gene mutat includ recent publish group increa ingli appli howev number mutat detect method among reason compromis singl gene test genomewid tool purpos mutat detect gene express small dedi cate microarray also known boutiqu array base experi boutiqu microarray design product data decid creat small microarray dedic gene express profil amlarray main aim studi test util array verifi select result polymeras chain reaction approach standard realtim ddpcr examin gene express group patient analysi includ polish adult patient novo prior therapi classifi subtyp myeloid arrest first stage group patient previous perform compar proteom analysi without matur addit studi compar present result earlier proteom result data hope find novel factor gene group gene express pattern gene molecular clinic correl analys valuabl shown differ among individu patient genom still incomplet materi method sampl peripher blood bone marrow sampl collect adult patient adult healthi volunt individu provid sign inform consent treat ment studi appropri approv also obtain bioethic commiss karol poznan univers medic scienc poznan poland patient diagnos treat depart hematolog bone marrow poznan univers hospit lord univers medic scienc poznan poland standard therapi use cytosin arabinosid plu patient induc complet remiss defin accord european leukemia guid line avail sampl collect follow timepoint diagnos prior first therapi establish start induct therapi diseas relaps howev sampl number cell much lower cell sampl often suffici materi perform replic experi moreov micro array imag requir qualiti criterion filter materi timepoint preliminari microarray analysi reveal sampl cluster togeth exhibit clear common sampl gener similar sampl abl distinguish cluster therefor decid limit analys sampl collect timepoint avail inform histori treatment advantag select sampl homogen fraction blood bone mononuclear cell isol patient contain leukem cell wherea patient contain myeloblast tabl present summar informa tion patient sampl cell separ mononuclear cell form peripher blood term pbmc bone marrow term bmmc separ densiti gradient gradisol aquamedica bogucin poland wash time salin mgfree ibss biom warsaw poland cell pellet suspend lysi buffer mirvana mirna isol journal oncolog fisher scientif waltham immedi frozen isol total extract pbmc bmmc use mirvana mirna isol dnase treat turbo dnafre fisher scientif integr evalu bioanalyz total nano assay agil santa clara rna integr number use gene express analys microarray screen literatur enabl identifi follow group gene proven postul acut leukemia biomark gener oncogen predict involv leukem addit select control gene human gene associ oncogenesi use posit control wherea plant gene serv neg control order chemic synthes amino modifi microarray probe compani ocimum hyderabad india probe operon gmbh cologn germani probe addit control use short probe institut biophys warsaw poland probe complemen tari extern spike rna fisher scientif random oligo probe operon gmbh total microarray contain uniqu probe probe human gene probe specif bacteri gene probe specif plant gene artifici control probe probe dilut pronto epoxid spot solut spot triplic onto slide corn york spotarray instrument perkinelm waltham design amlarray deposit databas access label microarray quantiti total sampl revers transcrib use anchor dntp superscript revers superscript plu indirect cdna label system invitrogen carlsbad amino modifi cdna patient label alexa fluor refer cdna cell line sampl obtain marcin schmidt poznan univers life scienc alexafluor label cdna purifi minelut reaction cleanup qiagen hilden germani dissolv buffer bsaml kept prior corn microarray chamber perkinelm water bath use stepdown protocol three subsequ wash step appli tabl sampl summari gener inform count microarray sampl sampl total rang rang realtim ddpcr sampl median unknown median individu sampl experi experi mutat statu sampl patient micra sampl respect treatment respons crshort crlong patient micra ath number includ microarray experi white blood cell count healthi volunt control acut myeloid leukemia resist therapi complet remiss crshort last year crlong last year death therapi intern tandem duplic gene rtqpcr revers ddpcr droplet digit handschuh gene express profil acut myeloid leukemia room temperatur room temperatur slide dri microarray highspe centrifug arrayit corp sunnyval room temperatur scan system perkinelm resolut microarray data analysi microarray imag process use genepix version softwar molecular devic sunnyval spot meet criterion satur filter data file deposit databas acc sion load version develop core team process analyz limma packag briefli fore ground background median signal valu exclud weight subtract method normal global loess method probe replic averag replic array patient merg gene express test use linear model suitabl experi ment common refer design final pvalu adjust correct data cluster conduct visual heatplu packag realtim analysi dnafre sampl revers transcrib use superscript oligodt invitrogen reaction mixtur incub addit enzym ad first hour follow revers sampl incub naoh ad cdna overnight ethanol sodium acet centrifug pellet wash twice ethanol dissolv total cdna dilut serv templat realtim reaction includ mesa green qrtpcr mastermix plu eurogentec serum belgium primer specif transcript refer gene actb gapdh ppia last select stabl use genorm sequenc primer present tabl gene analysi perform duplic standard gener hela cdna templat obtain result revers control hela superscript plu indirect cdna label system invitrogen realtim analysi perform rotorgen qiagen use follow program initi cycl dena turat anneal elong final elong final hold melt curv gener rang reaction volum reaction perform triplic realtim product verifi melt curv analysi product quantiti estim use standard curv method valu obtain triplic averag result obtain biolog replic separ revers reaction separ realtim analys averag divid averag replic refer gene droplet digit analysi dnafre sampl revers transcrib purifi describ realtim except reaction last enzym use cdna dissolv serv templat ddpcr system evagreen ddpcr supermix biorad hercul primer specif candid gene refer gene reaction volum primer volum cdna optim candid gene sampl condit follow initi cycl anneal elong cool final final hold tempera ture ramp rate follow plate directli analyz droplet reader data process use quantum soft version softwar biorad number droplet candid gene divid number droplet obtain refer enc gene analyz multiplex reaction reaction perform duplic sequenc primer present tabl statist analysi rtqpcr data statist analys plot made version studio version welch sampl ttest unpair appli pairwis comparison anova appli comparison across group moreway anova tukey honestli signific differ test base multipl comparison mean appli determin pairwis comparison signific test express valu gene particular gene express clinic data pearson calcul threshold pvalu alway databas screen follow opensourc softwar tool databas explor ncbi databas wwwncbi nlmnihgov includ pubm gene gene express omnibu gdsbrowser express atla ebiacukgxa david result microarray analysi studi gene express design small boutiqu amlarray deposit databas array contain long probe human gene implic inter alia cell matur apoptosi leukem gene function analysi david reveal microarray journal oncolog enrich gene link immun infect cancer class diseas omim diseas found signific gene cover amlarray encod protein follow kegg pathway cancer gene receptor interact gene jakstat signal gene chemo kine signal gene mapk signal gene focal adhes gene cell lineag gene regul actin gene amlarray use estim rel gene expr sion pbmc andor bmmc obtain novo patient prior therapi tabl sampl classifi subtyp basi earli blast cell differ entiat arrest either myeloid cell matur partial matur microarray experi base twocolor wherein studi sampl match common refer cell line data deposit databas access back normal technic replic probe array merg analyz use limma packag first ass whether differ bmmc pbmc similar proteom analysi result previou studi signific differ amlpbmc amlbmmc express analysi limma linear model adjust pvalu tabl therefor follow transcrip tome analys divid sampl bmmc pbmcderiv group next identifi differ sampl assum level threshold select express gene deg tabl howev sampl cluster deg sampl still sampl includ cluster cluster applic restrict threshold limit list deg underex press tabl total gene tabl primer product gene ncbi nucleotid primer sequenc length gene descript refer forward revers name annexin actb actin beta catalas gapdh kina ppia isomeras calcium bind protein calcium bind protein stathmin wilm tumor primer sequenc refer gene actb ppia studi losso primer studi hussein primer studi kreuzer design remain primer melt temperatur calcul support ncbi primer blast handschuh gene express profil acut myeloid leukemia tabl summari microarray data analysi result smallest adjust pvalu deg comparison gene gene gene amlpbmc ctsg amlbmmc srgn gene tabl gene tabl cbfb cybb fosb ctsg ighm junb mylpf ppif procr rhag rhoh srgn ctsg ctsg srgn nfkbia kitlg rhoh actb cbfb ctsd ctsg ighm gapdh mylpf procr ptpre kitlg rara rhag rhob ppif tubb tradd pdgfrb dntt cebpb cybb gapdh fosb prodh ptpre rhoh tubb nfkbia gapdh tubb cbfb ptpre rara rhob ighm rara journal oncolog tabl continu smallest adjust pvalu deg comparison gene gene gene fosb ighm prame tiparp kitlg rhoh tubb tert ogfr tert remain ogfr tert remain amla dntt remain tradd remain amla dntt fosb stom remain fosb prodh rhoh fosb remain amla fosb remain remain amla prodh stom remain rhoh rhoh prodh remain amla nono canx remain nubpl remain amla nubpl canx canx canx cebpb canx amla pklr prkcq amla nubpl amla nubpl gapdh tert nfkbia nubpl gapdh tert nfkbia nubpl gapdh cflar prame rbpm tert aven amla prame ighm cflar sirpa stom mafb handschuh gene express profil acut myeloid leukemia list equal proport encod protein involv signal tran scription regul affect process cell growth adhes apoptosi note gene associ function gene exclus engag immun inflam matori respons deg abl perfectli distinguish sampl entir array clearli divid cluster control sampl constitut separ cluster wherea sampl belong second cluster consid anoth criterion level express select list deg gene greatest chang express valu equival chang express direct overex press gene close equal enrich encod protein involv regul microtubul filament system stathmin also signific gene comparison sampl adjust pvalu tabl upregul gene encod protein associ myeloid leukemia cancer develop oncogen cell cycl apoptosi regul bind protein cebpa kirsten sarcoma viral oncogen homolog kra vmyc viral oncogen homolog avian kina mainten complex compon nuclear ckit ligand kitlg serglycin srgn protein involv cell growth glucos metabol regul enolas ribo somal protein among gene encod protein follow cell surfac receptor fragment ficolin typic express peripher blood leukocyt agent lysozym tumor necrosi factor famili member lymphotoxin interferon induc protein calcium bind protein moreov decreas gene express observ cell cycl regul protein tyrosin phosphatas ptpre apoptosi suppressor baculovir regul actin cell migrat differ entiat thymosin membran skelet protein adducin determin whether subtyp could use boutiqu array compar gene express profil obtain patient diagnos patient classifi howev detect signific differ enc adjust pvalu tabl separ analysi reveal deg among deg comparison share list deg obtain comparison thu suggest subtyp subset latter show uniqu featur list gene share subtyp includ gene shown apart srgn ptpre uniqu comparison gene share express tradd nfkbia pdgfrb gene uniqu belong actb rhoh gene list gene uniqu includ inter alia tabl continu smallest adjust pvalu deg comparison gene gene gene amla sirpa mafb crlong cast crebbp crshort cast ptprc crlong cast crshort amla ptprc ath analysi repeat sampl without analys perform limma packag linear model express gene deg identifi level pvalu correct multipl test signific gene identifi comparison tabl includ gene rank accord pvalu parenthes set gene common multipl comparison cebpa kra gene common comparison junb srgn gene common comparison pdgfrb tradd gene common comparison nfkbia ralgd gene common comparison journal oncolog figur heatmap present normal express valu gene select acut myeloid leukemia compar healthi volunt sampl vertic adjust pvalu threshold dendrogram repres result cluster gene left side heatmap sampl heatmap white point mean miss valu refer probe weight exclud analysi poor qualiti chang express valu gene select green compar sampl gene rank accord valu figur heatmap present normal express valu acut myeloid leukemia amlarray gene studi sampl healthi volunt sampl exclud dendrogram repres result cluster gene left side heatmap sampl heatmap white point indic miss valu refer probe weight exclud analysi poor qualiti reveal exist outlier sampl first sampl right three sampl left major cluster middl sampl collect left side heatmap show gener homogen sampl clear sampl cluster cannot handschuh gene express profil acut myeloid leukemia ctsg ctsd gapdh tubb junb encod marker protein matur regard effect mutat analyz gene express profil follow subgroup patient typic subtyp patient mutat patient owe coexist mutat patient also abl distinguish addit subgroup patient patient patient howev abl identifi distinct cluster detect signific differ comparison tabl last result worth mention regard analysi use amlarray patient accord respons therapi associ gene express prognosi treatment outcom clinic import aspect leukemia studi although studi sampl collect time diag nosi monitor patient enabl divid gener subgroup respons therapi patient reach complet remiss patient patient resist therapi patient patient succumb diseas therapi patient subgroup divid smaller subgroup patient complet remiss last year crshort patient patient complet remiss last year crlong patient detect signific differ gene expr sion subgroup tabl analys perform amlarray signific differ detect subgroup compar notabl obtain list deg despit variabl length consist high number share gene alway rank tabl elimin impact repeat analys focus sole sampl result signific differ detect subgroup apart gene encod dase remain sampl tabl cluster data also indic patient gener alli homogen group despit individu variat realtim analysi verifi result microarray analysi select gene quantifi express realtim figur result realtim pcrbase express analysi gene acut myeloid leukemia compar healthi volunt sampl context subtyp context respons therapi divid subgroup subgroup crlong crshort yax show rel express valu studi gene compar refer gene plot contain anova pvalu obtain whole test pairwis comparison signific differ verifi ttest tukey test indic letter asterisk symbol bar show letter indic signific differ number asterisk denot level statist journal oncolog rotorgen instrument case sampl contain sampl gene select upregul gene compar select upregul subgroup wherea select gene differ subgroup compar tabl statist signif icanc amlcr subgroup tabl howev interest whether gene belong gene famili present similar express pattern first owe variabl express mani socal test commonli use refer gene actb gapdh ppia express stabil gene across sampl estim genorm ppia indic stabl wherea gapdh variabl show trend toward sampl data shown find consist result microarray analysi gapdh list deg sampl final refer gene ppia use factor gene expr sion analyz context subtyp mutat statu respons therapi fig consist result microarray realtim experi obtain gene induc compar although fold chang somewhat lower compar almost chang microarray data analysi similar micro array data analysi result visibl subgroup compar ttest fig signific differ express particular subgroup follow except highest express observ subgroup regard gene express observ trend toward howev increas express signific comparison ttest realtim pcrbase analysi gene confirm gener suppress trend least subgroup compar express level rel gene code protein highli correl pearson correl pvalu howev signific decreas observ subtyp compar ttest well ttest ttest mutat statu figur result realtim pcrbase express analysi gene acut myeloid leukemia compar healthi volunt sampl divid accord mutat statu togeth yax show rel express valu studi gene compar refer gene plot contain anova pvalu obtain whole test pairwis comparison signific differ verifi ttest tukey test indic letter asterisk symbol bar show letter indic signific differ number asterisk denot level statist handschuh gene express profil acut myeloid leukemia ttest ttest subgroup ttest comparison result proteom studi group sampl also previous analyz proteom analysi labora torus studi attempt compar result proteom analys howev owe limit approach comparison could made small subset amlarray consist probe complemen tari gene human gene howev analysi proteom enabl detect protein much human protein detail uniqu protein detect proteom studi probe amlarray identifi protein determin differen tialli accumul studi sampl repres amlarray probe probe relat gene gene famili half result proteom analys concord partial concor dant half discord tabl droplet digit analysi verifi discrep anci proteom result appli anoth method ddpcr precis sensit accur type expand research group sampl sampl analysi perform droplet digit system biorad select gene encod annexin encod catalas determin accumul proteom analys none gene identi fie amlarray express express trend concord discord type posit control use oncogen slightli increas amlr compar microarray experi analyz wilm tumor gene recent describ relev acut leuk mia includ amlarray probe refer gene select basi previou realtim analysi regard gene abl multiplex reaction refer gene differ product size tabl gene refer gene analyz separ reaction alway within figur result ddpcrbase express analysi gene acut myeloid leukemia compar healthi volunt sampl context subtyp context respons therapi divid subgroup subgroup crlong crshort yax show rel express valu studi gene compar refer gene plot contain anova pvalu obtain whole test pairwis comparison statisti callus signific differ verifi ttest tukey test indic letter asterisk symbol bar show letter indic signific differ number asterisk denot level statist journal oncolog data duplic experi separ process quantum soft version softwar biorad rel express valu gene calcul ratio droplet number studi gene refer enc gene result statist analysi perform present fig posit control gene reveal trend toward signific tukey test tukey test gene expr sion also upregul sampl compar sampl tukey test differ follow comparison tukey test tukey test tukey test gene gener express level trend toward overex pression howev greatest increas express observ signific differ express gene observ ttest confirm proteom result partial concord result obtain gene agreement proteom result observ signific increas express subgroup compar fig ttest ttest ttest ttest ttest ttest also detect signific increas express compar sampl ttest howev differ gene express level subtyp subtl signific ttest contrast proteom find ing regard respons therapi signific differ elev express observ crlong subgroup ttest ttest crlong regard gene ddpcr experi reveal evid signific gene subgroup wherea sampl express scarc detect abl ttest fig interest observ increas trend express subgroup higher level le respons therapi high figur result ddpcrbase express analysi gene acut myeloid leukemia compar healthi volunt sampl divid accord mutat statu togeth yax show rel express valu studi gene compar refer gene plot contain anova pvalu obtain whole test pairwis comparison signific differ verifi ttest tukey test indic letter asterisk symbol bar show letter indic signific differ number asterisk denot level statist handschuh gene express profil acut myeloid leukemia journal oncolog handschuh gene express profil acut myeloid leukemia journal oncolog tifi handschuh gene express profil acut myeloid leukemia level also detect sampl without muta tion harbor mutat differ across particular subgroup signific apart compari son upregul tukey test upregul without ttest tabl comparison result proteom studi protein identifi microarray protein gene proteom studi gene probe express concord actin present higher partial higher crshort higher crshort αactinin higher slightli lower aldoa aldoc present higher aldolas annexin higher higher differ higher lower annexin higher higher higher present higher arhgdib higher higher partial inhibitor higher higher slightli lower catalas higher higher higher slightli higher higher higher slightli higher αenolas higher higher protein higher glutathion gsto present higher transferas slightli lower tumor reject higher higher higher partial antigen lower lplastin lymphocyt present lower cytosol protein higher pyruv kina much higher higher purin nucleosid higher higher higher lower ppia ppif higher differ complex higher isomeras cyclophilin higher higher higher partial lower slightli lower protein higher slightli lower mere detect bind protein tropomyosin present higher lower partial much lower tubulin tubb higher higher higher partial lower protein ywhaz ywhaq higher higher slightli lower lower journal oncolog among molecular clinic featur order identifi link gene express measur rtqpcr mutat statu clinic patient perform seri statist test ttest twoway anova tukey multipl comparison mean pearson correl strongest observ count subtyp oneway anova count higher count mutat statu oneway anova count muta tion statu oneway anova count mutat statu twoway anova highest count observ mutat sampl regard effect observ moder posit correl patient gene express pearson correl moder ate neg correl express gene pearson correl pearson correl correla tion mutat statu oneway anova togeth twoway anova express gene pearson equal also find gene express level oneway anova pvalu equal count pearson equal note correl gene express mutat statu oneway anova presenc fusion gene correl molecular clinic gene express databas explor compar result gene express profil result explor gene express omnibu databas wwwncbi identifi relev dataset select dataset includ deriv affymetrix gene chip commonli use microarray platform agil microarray among dataset contain healthi control sampl dataset screen name gene identifi express particular subgroup use amlarray rtqpcr proteom tabl show result compar analysi percentag gene express trend concord data dataset rang mean rang mean includ partial concord gene express trend concord linesmicro array probe level coincid dataset much lower percentag concord gene remain rang mean rang mean includ partial concord gene refer discord gene oppo site effect could observ although differ smaller percentag discord gene compar analysi data data rang mean within dataset rang mean analyz gene express trend abl select strong candid gene express trend concord dataset dataset total gene cebpa increas compar normal control wherea decreas cebpb cybb ighm tradd mention list contain increas decreas gene present identifi gene highest express fold chang analysi gene identifi data proteom approach gene uptod describ biomark also worth mention member bind protein famili factor cebpa cebpb exhibit opposit express trend studi dataset regard subtyp analyz express trend gene includ gene encod protein deter mine accumul proteom approach gene identifi ddpcr comparison dataset refer differ stage matur observ concord result gene gene select proteom approach discus take advantag genom tool tremend progress molecular studi achiev although mani studi alreadi publish tabl result compar analysi data dataset dataset data data gene identifi express data use amlarray rtqpcr proteom consid number refer percentag concord gene trend express regular font number parenthes includ also partial concord gene discord gene opposit trend ital percentag valu calcul base number gene repres compar data set handschuh gene express profil acut myeloid leukemia area best knowledg research first analysi polish adult popula tion moreov group patient proteom analysi also perform number sampl high howev advantag subtyp signific enrich cnaml sampl previou analys often includ subtyp fewer patient present studi also report custommad array studi major research conduct affymetrix gene chip studi conduct larg cdna microar ray platform util array construct probe least sever thousand gene advantag boutiqu array lower price higher flexibl smaller laboratori compar analysi result result gene express studi base affymetrix gene chip prove util reliabl amlarray level concord even higher result dataset dataset howev still observ discord result gene dataset compar main reason discrep differ patient differ vari number sampl contribut tech nical biolog bia applic boutiqu array present herein enabl identifi gene howev abl detect signific differ subgroup lack success explain factor method effect enough studi sampl accur representa tion popul sampl size suffici limit method preselect gene could adequ distinguish particular subgroup homemad microarray product could also contribut technic bia compar commerci gene chip base experi microarray design produc tion data perform mani technic replic care inspect microarray imag filter slide respect qualiti criterion regard patient appli addit selec tion criterion includ patient classifi subtyp time project cluster reveal gener alli homogen addit studi subgroup repres sampl thu statist difficult achiev probabl substanti increas sampl size could overcom problem take account limit consid analysi alway treat firstlin screen tool precis gene expr sion need rtqpcr particular version ddpcr reliabl among gene present studi marker gene associ potenti biomark gene discus context report neoplasm leukemia gene often play fundament role cell metabol function explain need highli cancer cell gene encod stathmin formerli known oncoprotein gene observ gene confirm realtim consist result gene express studi highli express acut leuk mia lymphoma intens cell decreas induct cell good biomark candid potenti therapeut target possibl candid encod cyclin depend kina cell cycl regul prevent apoptosi encod protein abund earli myeloblast cell line similarli suppress numer gene sampl detect consist data literatur exampl among gene found signifi cantli cell obtain patient encod thymosin regul actin cell migrat express higher lymphoid lineag transcript level increas granulocyt matur propos marker differentia tion cell gene encod ficolin second downregu late gene microarray experi find report associ gene function role gene therefor subject studi diagnost point view import correl gene express class type diseas exampl distinct frequent close relat subtyp chal leng microarray analys usual result clear separ frequent cytogenet aberr subtyp wherea subtyp usual analyz proteom succeed determin five protein higher level three protein catalas annexin lplastin probe amlarray none gene express subtyp howev ddpcr sensit type express despit gener detect sampl definit higher compar well result prove use annexin potenti biomark protein transcript level case protein result found data data implic util marker protein level explain follow gene express exclus regul instead abund protein control journal oncolog level lifetim protein transcript vari differ synthesi degrad rate moreov transcript protein isoform synthes altern splice vogel marcott claim protein variat determin mrna abund weak correl lack correl gene express cell tissu also present rtqpcrbase analys enabl gene signifi cant express subtyp decreas increas compar consist observa tion express wilm tumor gene limit immatur leukemia invers correl cell differ entiat regard gene encod calcium bind protein implic cell cycl regul cell growth progress cancer data literatur report mani solid tumor type late myeloblast monoblast leukem cell line report childhood data indic high varianc gene express within sampl similar conclus drawn result obtain nkaml sampl cluster major subgroup associ high expr sion gene second associ express agreement result major sampl express level wholegenom analys enabl deter minat gene express signatur specif subgroup harbor frequent mutat amlarray abl identifi gene exhibit signific differ expr sion level sampl encod mast cell gene whose express higher sampl compar remain also identifi fourth upregul gene comparison older patient rtqpcr analys sampl also reveal increas level gene sampl sampl sampl gene express pattern consist result studi whitman report upregul gene compar wildtyp contrast describ herein author link elev express gene presenc associ gene muta tion discus analyz subgroup observ express gene use ddpcr exhibit highest express crlong group wherea gradual increas resist treatment result obtain catalas remain consist describ catalas regul sublin high express gene postul tumor suppressor describ lymphoma leukemia correl express prognosi also report conclus present studi small array design gener labora torus despit limit suitabl preliminari gene express studi although mani gene identifi amlarray confirm literatur show gene encod basic metabol protein gapdh also contribut though discus context data deposit public avail repositori download reanalyz research despit lack success particular subgroup amlarray potenti appli stage first diagnosi base gene express profil also modifi elabor improv array version better rate diagnost prognost success howev accur transcript measur approach particular ddpcr appropri applic strategi enabl obtain result valu abl form diagnost prognost point view identifi three gene whose express level use subtyp usual difficult distinguish show first time gene mutat statu correl high express posit respons treatment studi financi support polish ministri scienc higher educ grant studi also support polish ministri scienc higher educ spub know program grate marcin schmidt poznan univers life scienc provid cell would also like thank joanna alicja szabelska beręsewicz professor idzi siatkowski poznan univers life scienc assist micro array data compet interest author declar compet interest refer estey döhner acut myeloid leukaemia lancet döhner estey amadori appelbaum büchner burnett dombret fenaux grimwad larson european leukemianet diagnosi manag acut myeloid leukemia adult expert panel behalf european leukemianet blood handschuh gene express profil acut myeloid leukemia bennett catovski daniel flandrin galton gralnick sultan propos revis criterion acut myeloid leukemia report french cooper group intern vardiman thiel arber brun borowitz porwit harri beau tefferi revis world health myeloid neoplasm acut leukemia rational import chang blood döhner implic molecular acut myeloid leukemia hematolog hematol educ program washington grimwad hill independ prognost factor outcom hematolog hematol educ program washington falini acut myeloid leukemia mutat molecular clinic featur cancer treat nakao yokota iwai kaneko horiik kashima sonoda fujimoto misawa intern tandem duplic gene found acut myeloid leukemia leukemia chen tsay tang shen huang cebpa mutat acut myeloid leukemia patient cebpa mutat biallel mutat show distinct immuno phenotyp leukem cell clin cancer care valk goodev abuduhi geertsma kleinekoort wilson gari peak löwenberg reilli incid prognosi ckit mutat core bind factor acut myeloid leukaemia haematol tyner erickson deining willi eid levin heinrich gattermann gilliland druker sequenc screen reveal novel mutat myeloid leukemia patient blood delhommeau dupont della vall jame trannoy massé kosmid couedic robert alberdi mutat myeloid cancer engl ding walter mclellan lamprecht larson kandoth payton bati welch mutat acut myeloid leukemia engl aref kamel areida abdel aaal adam elghonemi elbaiomi zeid preval clinic effect mutat among cytogenet ical normal acut myeloid leukemia patient clin lymphoma myeloma leuk mrózek marcucci paschka whitman bloomfield clinic relev mutat gene express chang adult acut myeloid leukemia normal readi priorit molecular blood bacher kohlmann haferlach gene express profil diagnosi therapi acut leukaemia cancer treat riva luzi pelicci genom acut myeloid leukemia next gener front oncol kohlmann grossmann nadarajah haferlach sequenc feasibl haematolog haematol golub slonim tamayo huard gaasenbeek mesirov coller down caligiuri molecular cancer class discoveri class predict gene express monitor scienc alizadeh eisen davi sabet tran powel yang marti moor lymphochip special cdna microarray analysi gene express normal malign lymphocyt cold spring harb symp quant biol bulling döhner bair fröhling schlenk tibshirani döhner pollack profil identifi prognost subclass adult acut myeloid leukemia engl valk verhaak beijen erpelinck barjesteh waalwijk boer beverloo moorhous spek löwenberg use profil acut myeloid leukemia engl bacher kohlmann haferlach haferlach gene express profil acut myeloid leukaemia best pract clin haematol alcalay tiacci bergoma bigerna venturini minardi meani diverio bernard tizzoni acut myeloid leukemia bear cytoplasm npmc show distinct gene express profil gene involv stemcel mainten blood huang zhou yang shang wang wang wang zhou signatur normal acut myeloid leukemia hematol radmach marcucci ruppert mrózek whitman vardiman paschka baldu kolitz cancer leukemia group independ prognost signatur adult acut myeloid leukemia normal karyotyp cancer leukemia group studi blood wilson davidson martin andri potter harvey kopecki ankerst gene express profil adult acut myeloid leukemia identifi novel biolog cluster risk outcom predict blood handschuh goralski tomaszewski kazmierczak lewandowski komarnicki blazewicz figlerowicz detect mutat copi number variat acut myeloid leukemia use multiplex probe mutat oshlack emsli corcoran smyth boutiqu twocolor microarray high proport express probe genom biol uszczyńska handschuh szabelska kaźmierczak woronowicz kozłowski sikorski komarnicki siatkowski analysi boutiqu array univers method select optim data normal izat procedur wenn handschuh urbaniak formanowicz całkiewicz brzozowska figlerowicz węgrzyn wróbel applic microarray tech nolog element sequenc fish genom biol zmieńko urbaniak pląder formanowicz figlerowicz tile microarray global analysi chloroplast genom express cucumb plant plant method luczak kaźmierczak handschuh lewandowski komarnicki figlerowicz compar proteom analysi acut myeloid leukemia without matur proteom kaźmierczak luczak lewandowski handschuh czyż jarmuż gniot michalak figlerowicz komarnicki esteras gamma actin level might predict result induct therapi patient acut myeloid leukemia without matur oncol miller ding raphael mungal robertson hoadley trich laird bati cancer genom atla research network genom epigenom landscap adult novo acut myeloid leukemia engl smyth limma linear model microarray data biolog solut use gentleman carey dudoit irizarri huber springer york benjamini hochberg control fals discoveri rate practic power approach multipl test stat huang sherman lempicki systemat int grativ analysi larg gene list use david resourc protoc bergmann mieth maurer brieger karaka weidmann hoelzer high level wilm tumor gene mrna acut myeloid leukemia associ wors longterm outcom blood journal oncolog ding wang song zhao wilm tumor gene neg prognost indic acut myeloid leukemia plo wouter löwenberg delwel decad genom wide gene express profil acut myeloid leukemia flashback prospect blood haferlach kohlmann schnittger duga hiddemann kern schoch global approach diagnosi leukemia use gene express profil blood payton chang murakami geiss link nagarajan watson high throughput digit mrna abund primari human acut myeloid leukemia sampl clin invest gutiérrez lópezpérez hernández isidro gonzález delgado fermiñán garcía vázquez gonzález gene express profil reveal gene relev function differ subclass acut myeloid leukemia leukemia andersson edén lindgren nilsson lassen heldrup font borg mitelman johansson gene express profil leukem cell line reveal conserv molecular signatur among subtyp specif genet aber ration leukemia park yang seong gene express profil relat prognosi acut myeloid leukemia oncol tsushima ando itonaga imaizumi imanishi iwanaga taguchi fukushima yoshida express gene mutat patient normal karyotyp doubl cebpa mutat associ high percentag posit leukem blast hematol cristóbal garciaorti cirauqui calasanz odero recurr event associ poor outcom contribut protein phosphatas inhibit acut myeloid leukemia castellvi garcía hernández ramón cajal lleonart express ribosom protein gynecolog tumor pathol tsai chien shen wong hsiao wang shih potenti prognost head neck cancer marker promot transfor mation partli chemokin induct cancer rowland william jone guest reynold barber brown stathmin express featur cell cell lineag invest roo brattsand landberg marklund gullberg express oncoprotein human leukemia lymphoma leukemia johnson jone rowland william guest brown stathmin associ induct cell growth arrest agent feb lett matushanski radparvar skoultchi leukem cell termin inhibit specif kina proc natl acad müller lang gaiser hofmann bartel feller merz express receptor cell patient myeloid leukemia leuk tagliafico tenedini manfredini grand ferrari roncaglia bicciato zini salati bianchi molecular signatur predict sensi tiviti induct acut myeloid leukemia leukemia qian fernald godley larson beau express profil cell reveal distinct subtyp acut myeloid leukemia proc natl acad shimamura kudo kondo dohmen gondo okamura ishibashi niho express thymosin beta gene cell blood wolf selbach bus synthesi degrad jointli determin cellular proteom bioessay vogel marcott insight regul protein abund proteom analys genet chen gharib huang taylor misek kardia giordano iannettoni orring hanash discord protein mrna express lung adenocar cinoma cell proteom jansen greenbaum gerstein relat wholegenom express data genom miwa beran saunder express wilm tumor gene human leukemia leukemia elrifai moskaluk abdrabbo harper yoshida riggin frierson powel gastric cancer overexpress protein cancer wang express lung correl clinic featur chin engl whitman maharri radmach becker mrózek margeson holland schwind metzel intern tandem duplic associ advers outcom gene signatur patient year older primari normal acut myeloid leukemia cancer leukemia group studi blood choi catalas gene express sublin biochem biophi commun bergmann maurer weidmann wilm tumor gene express acut myeloid leukemia leuk lymphoma losso czerwinski wechser levi realtim rtpcr paramet studi lymphoid leukemia hussein michael brabant omri narain passi ramana parrillo kumar parissenti human septic serum induc gene express modul human myocyt clin kreuzer saborowski lupberg appelt coutr schmidt fluoresc assay absolut wilm tumour gene mrna monitor human leukaemia haematol work licens creativ common byncnd licens